Kolibaba, KS, Druker BJ. Current Status of Treatment for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 [formerly published in Medscape Hematology-Oncology eJournal 3(2), 2000]. Available at ...
Kolibaba, KS, Druker BJ. Current Status of Treatment for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 [formerly published in Medscape Hematology-Oncology eJournal 3(2), 2000]. Available at ...
Frontline tyrosine kinase inhibitors are well-established for chronic myelogenous leukemia, but some patients experience inadequate response or adverse events, highlighting the need for novel ...
They are chronic and slowly get worse over time. The different types of myeloproliferative disorders depend on which cells are overproduced. These conditions include chronic myelogenous leukemia, ...
Many important clinical conditions like Down syndrome and chronic myelogenous leukemia result from translocation mutations. A change in chromosome structure and content caused by translocation ...